ACADIA PHARMACEUTICALS INC. (ACAD) /

The profitability of ACADIA PHARMACEUTICALS INC. over the past 10 years

Chart ACADIA PHARMACEUTICALS INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

ACADIA PHARMACEUTICALS INC. reported net income of $391M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $982.51M and operating income of $104.81M. It reported a profit in 2 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021, 2022 and 2023.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$982.51M*$104.81M$391M
2024ended Dec 31, 2024$875.96M*$230.79M$226.45M
2023ended Dec 31, 2023$684.8M-$73.38M-$61.29M
2022ended Dec 31, 2022$507.07M-$223.6M-$215.97M
2021ended Dec 31, 2021$473.3M-$170.44M-$167.87M
2020ended Dec 31, 2020$431.54M-$286.59M-$281.58M
2019ended Dec 31, 2019$327.73M-$246.54M-$235.26M
2018ended Dec 31, 2018$211.43M-$247.44M-$245.19M
2017ended Dec 31, 2017$115.82M-$292.41M-$289.4M
2016ended Dec 31, 2016$14.25M-$272.81M-$271.39M

Fiscal years as ACADIA PHARMACEUTICALS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ACADIA PHARMACEUTICALS INC.

Companies of a similar size

Not investment advice. This page shows what ACADIA PHARMACEUTICALS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.